Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 2 of the last 2 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 13 % of short-term debt in 2025; threshold 65 %.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
Dr. E. Özpak from Gent, company number BE1002169158, closed financial year 2025 with a result of € -3,517 after tax. For that financial year Dr. E. Özpak recorded a gross margin of € -51 and equity of € -5,855. Compared with financial year 2024, the result moved from € -5,838 to € -3,517. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on January 30, 2026.
€ -5,855
▼ € 3,517 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -3,517
▲ 40 % less loss than in 2024
Profit after tax over the fiscal year.
€ 1,186
▼ 34% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -9,355.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 3,882
▼ 17% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 130
▲ 60% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € -2,562 | € -51 | ▲ € 2,511 |
| Profit after taxes | € -5,838 | € -3,517 | ▲ € 2,321 |
| Equity | € -2,338 | € -5,855 | ▼ € 3,517 |
| Total debts | € 10,106 | € 12,104 | ▲ 20% |
| Cash | € 1,797 | € 1,186 | ▼ 34% |
| Retained profit | € -5,838 | € -9,355 | ▼ € 3,517 |
| Balance sheet total | € 7,768 | € 6,249 | ▼ 20% |
Key figures of Dr. E. Özpak, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to Dr. E. Özpak?
What happened at Dr. E. Özpak in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 3,517. Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Gent. KBO
- Emine Özpak became a director. NBB
In short
From € 5,838 loss in 2024 to € 3,517 loss in 2025.
Paid € 211 in corporate taxes since 2024.
Management
Behind Dr. E. Özpak is Emine Özpak.
Directors
According to the 2025 annual accounts
Emine Özpak
Director
since 2023
Establishments
Establishment units
Physical locations of this company
Moortelputstraat 8
9031 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- Emine Özpak(oprichter) 100%
Details
- Company number
- 1002.169.158
- VAT number
- BE 1002.169.158
- Registered office
- Moortelputstraat 8, 9031 Gent
- Names & denominations
- Dr. E. Özpak
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 November 2023
- Peppol
- Not registered